FOURTH AMENDMENTLease • May 9th, 2014 • Repligen Corp • Biological products, (no disgnostic substances)
THIS FOURTH AMENDMENT TO LEASE (the “Amendment”) is made and entered into as of the date of final execution (“Effective Date”), by and between CENTERPOINT ACQUISITIONS LLC, a Delaware limited liability company (“Landlord”), and REPLIGEN CORPORATION, a Delaware corporation (“Tenant”).
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • May 9th, 2014 • Repligen Corp • Biological products, (no disgnostic substances) • California
This Asset Purchase Agreement (this “Agreement”) is made and entered into as of January 21, 2014 (“Effective Date”) between BioMarin Pharmaceutical Inc., a Delaware corporation, with offices at 105 Digital Drive, Novato, CA 94949, (“BioMarin”) and Repligen Corportion, a Delaware corporation with offices at 41 Seyon Street, Building 1, Suite 100, Waltham, MA 02453 (“Repligen”). Repligen and BioMarin shall also be referred to herein individually as “Party” and collectively as “Parties”.
